Korean Drug Co. Ltd (014570) — Capital Reinvestment Ratio
Korean Drug Co. Ltd (014570) has a Capital Reinvestment Ratio of 0.01x as of June 2026, meaning it reinvests 0% of its operating cash flow (₩1.90 Billion) in capital expenditures (₩17.20 Million). Check 014570 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Korean Drug Co. Ltd Capital Reinvestment Ratio (2014–2025)
This chart tracks Korean Drug Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see Korean Drug Co. Ltd operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Korean Drug Co. Ltd (2014–2025)
Year-by-year Capital Reinvestment Ratio for Korean Drug Co. Ltd from 2014 to 2025. See Korean Drug Co. Ltd (014570) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | ₩13.11 Billion | ₩475.05 Million | ▼ -83.1% |
| 2024 | 0.21x | ₩4.87 Billion | ₩1.04 Billion | ▼ -79.2% |
| 2022 | 1.03x | ₩5.91 Billion | ₩6.09 Billion | ▲ +691.9% |
| 2021 | 0.13x | ₩8.81 Billion | ₩1.15 Billion | ▲ +117.3% |
| 2020 | 0.06x | ₩12.33 Billion | ₩738.47 Million | ▼ -87.8% |
| 2019 | 0.49x | ₩6.21 Billion | ₩3.05 Billion | ▲ +118.8% |
| 2018 | 0.22x | ₩5.79 Billion | ₩1.30 Billion | ▼ -91.1% |
| 2017 | 2.53x | ₩447.20 Million | ₩1.13 Billion | ▲ +2077.4% |
| 2016 | 0.12x | ₩3.96 Billion | ₩460.84 Million | ▼ -18.8% |
| 2015 | 0.14x | ₩6.13 Billion | ₩878.05 Million | ▲ +18.7% |
| 2014 | 0.12x | ₩4.46 Billion | ₩538.19 Million | — |